Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spinal disc implant to be sold in Europe:

This article was originally published in Clinica

Executive Summary

RayMedica, a small US developer of devices to treat back pain, has CE-marked its PDN prosthetic disc nucleus devices and instrumentation. The Minneapolis, Minnesota-based company plans to launch the PDN implant in all EU countries after it has trained groups of surgeons in each country. Two of the devices, which are hydrogel cores covered with woven polyethylene, are implanted within the spinal disc of patients with low back pain, where they expand by absorbing fluid, taking pressure off the disc.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT079256

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel